US FDA approves home-delivered tDCS for treating depression
On Dec 8, 2025, the US Food and Drug Administration (FDA) approved the Flow Neuroscience transcranial Direct Current Stimulation (tDCS) device for the treatment of “moderate to severe major depressive disorder (MDD) in the current episode, either as monotherapy or as an adjunctive treatment, in pati...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2026-01-01
|
| Ráidu: | Brain Stimulation |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S1935861X25004231 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|